PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11645336

Current and future issues in assisted reproduction.

LeRoy Walters
View original source ↗Export metadata ↓

Abstract

The last quarter of the twentieth century has given rise to reproductive technologies and arrangements that in the earlier part of the century could only be dreamed of by the authors of science fiction. We stand in the middle of this reproductive revolution, trying to cope with the developments that have already occurred but with an uneasy sense that the future may be even more complicated ethically than the past and the present. In this brief essay, I will survey recent ethical and public-policy discussions of two reproductive techniques (assisted insemination and in vitro fertilization) and one reproductive arrangement (surrogate motherhood). After distinguishing three phases in the normative debate, I will briefly comment on some of the characteristics of, and continuing ambiguities in, the ethical debate of the past 25 years. At the conclusion of the essay, I will attempt to anticipate three future issues in ethics and reproduction.

Explore related subjects

Advisory CommitteesArtificial OrgansContractsEvaluation Studies as TopicFemaleFertilization in VitroGenetic TherapyGerm CellsGuidelines as TopicHistoryHistory, 20th CenturyHistory, 21st CenturyHumansInsemination, ArtificialOocyte DonationParent-Child RelationsPreimplantation DiagnosisPublic PolicyReproductive Techniques, AssistedSocial ChangeSocietiesGestational CarriersTissue DonorsUnited StatesWomenWomen's RightsAmerican Fertility SocietyEthics Advisory BoardGenetics and ReproductionHistorical ArticleJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

LeRoy Walters. 1996. Current and future issues in assisted reproduction.. https://doi.org/10.1353/ken.1996.0047

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗